Free Trial

ZIVO Bioscience (ZIVO) Competitors

ZIVO Bioscience logo
$18.00 0.00 (0.00%)
As of 12:03 PM Eastern

ZIVO vs. RNAC, TSVT, ALMS, INZY, GLUE, TERN, PVLA, LFCR, TNGX, and GOSS

Should you be buying ZIVO Bioscience stock or one of its competitors? The main competitors of ZIVO Bioscience include Cartesian Therapeutics (RNAC), 2seventy bio (TSVT), Alumis (ALMS), Inozyme Pharma (INZY), Monte Rosa Therapeutics (GLUE), Terns Pharmaceuticals (TERN), Palvella Therapeutics (PVLA), Lifecore Biomedical (LFCR), Tango Therapeutics (TNGX), and Gossamer Bio (GOSS). These companies are all part of the "pharmaceutical products" industry.

ZIVO Bioscience vs.

ZIVO Bioscience (NASDAQ:ZIVO) and Cartesian Therapeutics (NASDAQ:RNAC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, community ranking, valuation, profitability, dividends and risk.

ZIVO Bioscience received 60 more outperform votes than Cartesian Therapeutics when rated by MarketBeat users. However, 95.12% of users gave Cartesian Therapeutics an outperform vote while only 60.74% of users gave ZIVO Bioscience an outperform vote.

CompanyUnderperformOutperform
ZIVO BioscienceOutperform Votes
99
60.74%
Underperform Votes
64
39.26%
Cartesian TherapeuticsOutperform Votes
39
95.12%
Underperform Votes
2
4.88%

ZIVO Bioscience has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500. Comparatively, Cartesian Therapeutics has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500.

ZIVO Bioscience has higher earnings, but lower revenue than Cartesian Therapeutics. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Cartesian Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZIVO Bioscience$15.85K4,330.22-$7.78M-$4.93-3.65
Cartesian Therapeutics$34.17M6.65-$219.71M-$52.83-0.17

ZIVO Bioscience has a net margin of 0.00% compared to Cartesian Therapeutics' net margin of -510.72%.

Company Net Margins Return on Equity Return on Assets
ZIVO BioscienceN/A N/A -2,240.92%
Cartesian Therapeutics -510.72%N/A -6.03%

Cartesian Therapeutics has a consensus price target of $43.00, suggesting a potential upside of 390.87%. Given Cartesian Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Cartesian Therapeutics is more favorable than ZIVO Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZIVO Bioscience
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cartesian Therapeutics
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

In the previous week, Cartesian Therapeutics had 10 more articles in the media than ZIVO Bioscience. MarketBeat recorded 10 mentions for Cartesian Therapeutics and 0 mentions for ZIVO Bioscience. Cartesian Therapeutics' average media sentiment score of 0.50 beat ZIVO Bioscience's score of 0.00 indicating that Cartesian Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
ZIVO Bioscience Neutral
Cartesian Therapeutics Neutral

12.8% of ZIVO Bioscience shares are owned by institutional investors. Comparatively, 86.9% of Cartesian Therapeutics shares are owned by institutional investors. 48.9% of ZIVO Bioscience shares are owned by company insiders. Comparatively, 57.9% of Cartesian Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Cartesian Therapeutics beats ZIVO Bioscience on 12 of the 17 factors compared between the two stocks.

Get ZIVO Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZIVO vs. The Competition

MetricZIVO BioscienceBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$68.63M$2.96B$5.39B$8.47B
Dividend YieldN/A1.63%5.28%4.16%
P/E Ratio-3.6931.7327.1419.88
Price / Sales4,330.22416.47392.38137.84
Price / CashN/A168.6838.3234.64
Price / Book-22.223.216.764.56
Net Income-$7.78M-$72.35M$3.23B$248.06M
7 Day PerformanceN/A-1.23%-0.13%0.19%
1 Month Performance-4.27%10.58%7.75%9.50%
1 Year Performance125.56%-24.67%18.92%8.76%

ZIVO Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZIVO
ZIVO Bioscience
N/A$18.00
flat
N/AN/A$68.63M$15,850.00-3.6910Positive News
RNAC
Cartesian Therapeutics
1.6366 of 5 stars
$10.37
+1.1%
$42.50
+309.8%
-62.7%$269.14M$34.17M-0.2064
TSVT
2seventy bio
1.3135 of 5 stars
$5.00
flat
$4.25
-15.0%
N/A$266.15M$48.37M-2.69440Positive News
ALMS
Alumis
2.5066 of 5 stars
$5.95
+5.9%
$24.86
+317.8%
N/A$265.38MN/A0.00N/AAnalyst Revision
INZY
Inozyme Pharma
2.9789 of 5 stars
$3.99
+1.0%
$11.75
+194.5%
-13.3%$257.60MN/A-2.5650High Trading Volume
GLUE
Monte Rosa Therapeutics
2.053 of 5 stars
$4.11
+3.3%
$15.50
+277.1%
-4.6%$252.81M$159.49M-2.2590Gap Up
TERN
Terns Pharmaceuticals
4.1386 of 5 stars
$3.15
+9.4%
$15.63
+396.0%
-49.7%$251.53MN/A-2.6740Positive News
PVLA
Palvella Therapeutics
3.804 of 5 stars
$22.56
+2.3%
$46.29
+105.2%
N/A$249.13M$42.81M-1.86N/A
LFCR
Lifecore Biomedical
1.2121 of 5 stars
$6.71
-2.6%
$8.00
+19.2%
+19.6%$248.44M$130.31M-11.98690
TNGX
Tango Therapeutics
1.4782 of 5 stars
$2.29
+52.7%
$12.33
+438.6%
-73.4%$248.22M$40.99M-1.9490Gap Up
High Trading Volume
GOSS
Gossamer Bio
3.8481 of 5 stars
$1.09
+4.8%
$7.75
+611.0%
+93.6%$247.67M$114.70M-3.41180Analyst Revision

Related Companies and Tools


This page (NASDAQ:ZIVO) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners